Navigation Links
Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile
Date:5/9/2008

TAMPA, Fla., May 9 /PRNewswire-USNewswire/ -- Osteoarthritis is a painful and potentially debilitating condition that affects almost 50 million people in the United States. It is caused by deterioration of cartilage in bone joints. The novel investigational pain medication tapentadol, a centrally acting oral analgesic, provided significant relief for patients with joint-disease pain, compared to those treated with placebo, and with fewer gastrointestinal side effects than those treated with an older, prescription pain reliever, researchers announced today.

Results from a Phase 3 clinical study of tapentadol immediate release (IR) tablets showed that patients treated with a 50 mg or 75 mg dose of tapentadol experienced significant relief in end-stage joint disease pain compared to placebo (P<0.001) when assessed over five days of treatment. In addition, patients treated with tapentadol experienced significantly better digestive tract tolerability compared to patients treated with 10 mg of oxycodone IR. Digestive tract tolerability is one of the leading causes of treatment discontinuation for patients who take prescription pain medications.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) presented these new data in a poster session at the 27th Annual Scientific Meeting of the American Pain Society (APS) in Tampa, Florida.

Tapentadol has a unique profile with two mechanisms of action, combining mu-opioid receptor agonism and norepinephrine reuptake inhibition in a single molecule. It is being developed in immediate-release formulation for acute pain and extended-release formulation for chronic pain.

Mu-opioid agonists are drugs that bind to and activate mu-opioid receptors in the central nervous system. These drugs modify sensory and affective (mood) aspects of pain, inhibit the transmission of pain at the spinal cord and affect activity at parts of the brain that control how pain is perceived. Nor
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development,L.L.C.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... NEW YORK , Nov. 26, 2014 /PRNewswire/ ... is growing at a rate of 4%, with ... according to Kalorama Information. MRI and other types ... the diagnosis and treatment of numerous medical conditions ... different technologies and techniques. Kalorama,s report, Medical ...
(Date:11/26/2014)... 25, 2014 According to ... Power Source (Electric, Battery, Pneumatic), by Product (Drill, ... Cart), by Application (Orthopedic, ENT, Oral, Thoracic, Neurology) ... global Powered Surgical Instruments Market is estimated to ... 2014 and is expected to grow at a ...
(Date:11/26/2014)... , Nov. 25, 2014  goBalto, Inc., the leading ... recognized as a winner of Red Herring,s Top ... Top 100 North America award in 2013, marking its ... landscape. Red Herring,s Top 100 Global list ... new companies and entrepreneurs. Red Herring editors were among ...
Breaking Medicine Technology:Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3
... TransTech Medical Solutions is pleased to announce the expansion ... Center.  The new agreement increases the suite of services ... transcription and voice recognition editing services across a variety ... medical transcription and editing services provided by TransTech can ...
... 14, 2010 Samplify Systems, Inc., a leading ... ultrasound market, is pleased to announce that its ... won Electronic Design Magazine,s Best Electronic ...  Details of Samplify,s AutoFocus™ beamforming technology currently appear ...
Cached Medicine Technology:TransTech Medical Solutions Expands Offering to MD Anderson Cancer Center to Include Outsourced Medical Transcription and Editing Services 2Samplify's AutoFocus™ Beamforming Technology Awarded Electronic Design's 'Best of 2010' 2
(Date:11/28/2014)... 2014 A newly released article ... of the influenza virus that will soon be spreading across ... The article begins with a brief explanation of what the ... reminds families that children under the age of 5, adults ... diseases, such as heart and lung diseases, asthma, or diabetes, ...
(Date:11/28/2014)... 28, 2014 Patten Pecans, based in ... With those passions driving them, they've added a pecan ... tried other pecans oils, they've found this pecan ... be exceptionally flavorful, retaining the buttery pecan notes that ... nutritional benefits found in pecans nuts is found ...
(Date:11/28/2014)... 28, 2014 Schools like Centra ... providing quality commercial playground equipment to its students. ... to supply an affordable play structure at its ... , Centra provides comprehensive programs for children who ... support services. They have served the needs ...
(Date:11/28/2014)... talklocal ( http://www.talklocal.com ) is ... service professionals by phone in about 90 seconds. , ... tornadoes were reported to have touched down just north of ... following the tornadoes, Denver residents now know all too well ... is like having local pros in over 50 service categories ...
(Date:11/28/2014)... 2014 Nipomo Family Dentistry , ... recently opened its doors at 195 N. Thompson St., ... preventative care like teeth cleanings, oral exams, fillings, implants ... teeth whitening (and Kor whitening), laser whitening, gum tissue ... Family Dentistry’s five-person team also takes a philanthropic approach ...
Breaking Medicine News(10 mins):Health News:How Flu Vaccines Can Impact Families Is Discussed in New Article from Community Health Center of Snohomish County 2Health News:Patten Pecans Goes Local with Nutritious Georgia Pecan Oil 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 3Health News:TalkLocal Launches In Denver A Week After Multiple Tornadoes Hit Near City 2Health News:Nipomo Family Dentistry Opens New Dental Office in Nipomo 2Health News:Nipomo Family Dentistry Opens New Dental Office in Nipomo 3
... Nov. 6 The following was released today,by ... recent report from the U.S. Department of Veterans ... substantiated waste,mismanagement and inaction to disclosures of fraud, ... Texas Veterans Health,Care System (CTVHCS)., Inaction to ...
... ) today reported results for the third quarter ended September,30, ... or $0.11 per,share, for the third quarter 2008 compared to ... the third quarter 2007. Cash and cash equivalents,totaled $6.1 million ... for the third quarter 2008 is due primarily to,a 26% ...
... vitality unclear, scientists say , , THURSDAY, Nov. 6 (HealthDay ... amounts of muscle-linked growth hormone in seniors to youthful ... therapy also gained muscle mass over the two-year trial, ... led to significant improvements in their strength or function. ...
... Conference Call Scheduled for Today - Thursday, November 6, 2008 at ... ... Calif., Nov. 6 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) reported ... 30, 2008, and provided an,update on its product development candidates. The ...
... MASI ), the inventor of Pulse CO-Oximetry(TM) and ... its,management is scheduled to present at the Lazard Capital ... York in New York, NY on,Wednesday, November 19, 2008, ... will be available on the Masimo website at, http://www.masimo.com ...
... RANCHO CORDOVA, Calif., Nov. 6 ThermoGenesis,Corp. (Nasdaq: ... that process and store adult stem cells, today reported ... for the quarter ended September 30, 2008, were $4.5 ... in the first quarter a,year ago. Disposable revenues were ...
Cached Medicine News:Health News:War Veterans With Traumatic Brain Injury Pay the Price of Waste at the VA, Says Dr. Robert Van Boven 2Health News:Pharmos Corporation Reports 2008 Third Quarter Results 2Health News:Pharmos Corporation Reports 2008 Third Quarter Results 3Health News:Pharmos Corporation Reports 2008 Third Quarter Results 4Health News:Pharmos Corporation Reports 2008 Third Quarter Results 5Health News:Drug Boosts Natural Growth Hormone in Seniors 2Health News:Drug Boosts Natural Growth Hormone in Seniors 3Health News:Drug Boosts Natural Growth Hormone in Seniors 4Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 2Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 3Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 4Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 5Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 6Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 7Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 8Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 9Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 10Health News:Masimo to Present at Lazard Capital Markets 5th Annual Healthcare Conference 2Health News:ThermoGenesis Reports First Quarter 2009 Results 2Health News:ThermoGenesis Reports First Quarter 2009 Results 3Health News:ThermoGenesis Reports First Quarter 2009 Results 4Health News:ThermoGenesis Reports First Quarter 2009 Results 5Health News:ThermoGenesis Reports First Quarter 2009 Results 6Health News:ThermoGenesis Reports First Quarter 2009 Results 7Health News:ThermoGenesis Reports First Quarter 2009 Results 8
Preference Toric quarterly planned replacement lenses are durable, easy to handle and virtually maintenance free. Meeting the needs of those suffering from astigmatism, these soft contact lenses are ...
... fit for all astigmatic patients. Ideal ... who require excellent visual acuity and ... of disposable lenses; astigmatic spectacle wearers ... lenses; and spherically masked astigmatic patients ...
C 2.3K with lightweight headband: the practical alternative for spectacle-wearers. Delivered in protective designer case....
... device that delivers ganciclovir intraocularly in ... This approach can significantly delay progression ... intravenous treatment. The Vitrasert implant contains ... that slowly releases the drug. The ...
Medicine Products: